These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 26576088)

  • 21. Inherited hepatocellular carcinoma.
    Villanueva A; Newell P; Hoshida Y
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):725-34. PubMed ID: 20955973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New possibilities in hepatocellular carcinoma treatment.
    Rasool M; Rashid S; Arooj M; Ansari SA; Khan KM; Malik A; Naseer MI; Zahid S; Manan A; Asif M; Razzaq Z; Ashraf S; Qazi MH; Iqbal Z; Gan SH; Kamal MA; Sheikh IA
    Anticancer Res; 2014 Apr; 34(4):1563-71. PubMed ID: 24692683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area.
    Lin MT; Chang KC; Chou YP; Tseng PL; Yen YH; Wang CC; Tsai MC; Cheng YF; Eng HL; Wu CK; Hu TH
    J Gastroenterol Hepatol; 2015 Feb; 30(2):345-51. PubMed ID: 25092265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
    Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer.
    Shiani A; Narayanan S; Pena L; Friedman M
    Cancer Control; 2017; 24(3):1073274817729240. PubMed ID: 28975833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
    Masuzaki R; Yoshida H; Tateishi R; Shiina S; Omata M
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1137-51. PubMed ID: 19187872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
    Ikai I
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):343-8. PubMed ID: 19068716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma: diagnostics and screening.
    Patel M; Shariff MI; Ladep NG; Thillainayagam AV; Thomas HC; Khan SA; Taylor-Robinson SD
    J Eval Clin Pract; 2012 Apr; 18(2):335-42. PubMed ID: 21114800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging techniques for the diagnosis of hepatocellular carcinoma and the evaluation of response to treatment.
    Hussain HK; Barr DC; Wald C
    Semin Liver Dis; 2014 Nov; 34(4):398-414. PubMed ID: 25369302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D; Han KH; Chan HL; Ueno Y;
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current management of hepatocellular carcinoma.
    Mendizabal M; Reddy KR
    Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.
    van Meer S; de Man RA; Siersema PD; van Erpecum KJ
    World J Gastroenterol; 2013 Oct; 19(40):6744-56. PubMed ID: 24187450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and management of hepatocellular carcinoma.
    Yang JD; Roberts LR
    Infect Dis Clin North Am; 2010 Dec; 24(4):899-919, viii. PubMed ID: 20937457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidisciplinary management of hepatocellular carcinoma: where are we today?
    Marrero JA
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S3-10. PubMed ID: 23457037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.